You are invited to attend an informative seminar detailing regulatory considerations and updated guidelines regarding the development and commercialization of cell and gene therapies. This seminar will feature Dr. Nimi Chhina, executive director and head of Global R&D and Regulatory Policy at BioMarin Pharmaceutical, Inc. Dr. Chhina will focus on key details surrounding:

• Unique regulatory considerations for cell and gene therapy product development
• Developing and informing a regulatory strategy for your project

Attendees will have the opportunity to sign up for a 1:1 meeting to discuss their project directly with Dr. Chhina. You must register and complete the meeting request form HERE in advance. Meetings will take place directly after the program. You will receive an invitation with the suggested timeslot once Dr. Chhina has reviewed all submissions.

This event is hybrid and will take place at Weill Cornell Medicine BioVenture eLab (1157 York Ave) for in-person attendees. Register here.